Cited by 157

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation

Wolfs, Ine, Donners, Marjo, de Winther, Menno·2011·Thrombosis and Haemostasis

Abstract

Summary: The phenotype of macrophages in atherosclerotic lesions can vary dramatically, from a large lipid laden foam cell to a small inflammatory cell. Classically, the concept of macrophage heterogeneity discriminates between two extremes called either pro-inflammatory M1 macrophages or anti-inflammatory M2 macrophages. Polarisation of plaque macrophages is predominantly determined by the local micro-environment present in the atherosclerotic lesion and is rather more complex than typically described by the M1/M2 paradigm. In this review we will discuss the role of various polarising factors in regulating the phenotypical state of plaque macrophages. We will focus on two main levels of phenotype regulation, one determined by differentiation factors produced in the lesion and the other determined by T-cell-derived polarising cytokines. With foam cell formation being a key characteristic of macrophages during atherosclerosis initiation and progression, these polarisation factors will also be linked to lipid handling of macrophages.

Overview

Integrity signals

Registry

Crossref · 10.1160/th11-05-0320

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 8 references

Research works printed but not linked: 64

  1. 10.2741/2692 · DOI · Paper page
  2. 10.1038/ni.1990 · DOI
  3. 10.1016/j.imbio.2010.05.031 · DOI
  4. Sinha, 2005, J Immunol, 174, 636, 10.4049/jimmunol.174.2.636 · DOI
  5. 10.1073/pnas.0809784106 · DOI · Paper page
  6. 10.1016/j.cmet.2007.06.010 · DOI · Paper page
  7. 10.1016/j.semcancer.2008.03.004 · DOI · Paper page
  8. 10.1681/ASN.2009060615 · DOI · Paper page
  9. 10.1161/CIRCRESAHA.109.215715 · DOI · Paper page
  10. 10.4049/jimmunol.0901368 · DOI
  11. 10.1016/S1074-7613(03)00174-2 · DOI
  12. 10.1146/annurev.immunol.021908.132557 · DOI
  13. 10.1172/JCI29950 · DOI
  14. 10.1172/JCI28549 · DOI · Paper page
  15. 10.1038/nri2415 · DOI
  16. 10.1016/S0021-9150(98)00263-9 · DOI
  17. 10.1177/41.10.7504008 · DOI
  18. 10.2174/157016110790886983 · DOI
  19. van, 1989, Lab Invest, 61, 166
  20. 10.1369/jhc.5A6871.2006 · DOI
  21. Buechler, 2000, J Leukoc Biol, 67, 97, 10.1002/jlb.67.1.97 · DOI
  22. 10.2353/ajpath.2009.080431 · DOI
  23. 10.1371/journal.pone.0008852 · DOI · Paper page
  24. 10.1161/CIRCULATIONAHA.110.984146 · DOI
  25. 10.1182/blood-2009-04-215020 · DOI
  26. 10.1073/pnas.0400983101 · DOI
  27. 10.1016/j.atherosclerosis.2010.11.023 · DOI
  28. Fleetwood, 2007, J Immunol, 178, 5245, 10.4049/jimmunol.178.8.5245 · DOI · Paper page
  29. 10.1016/j.atherosclerosis.2010.11.018 · DOI
  30. 10.2353/ajpath.2008.070513 · DOI
  31. 10.1016/j.imbio.2010.05.020 · DOI
  32. 10.1002/eji.200737042 · DOI
  33. 10.1016/0021-9150(93)90026-Q · DOI
  34. 10.1161/01.ATV.19.7.1726 · DOI
  35. 10.1172/JCI115261 · DOI
  36. 10.1161/01.ATV.17.11.2489 · DOI
  37. 10.1016/S0021-9150(99)00011-8 · DOI
  38. 10.1111/j.1440-1827.2009.02343.x · DOI
  39. 10.1189/jlb.0808497 · DOI
  40. Hansson, 1989, Am J Pathol, 135, 169
  41. 10.1002/(SICI)1096-9896(199906)188:2<174::AID-PATH333>3.0.CO;2-3 · DOI
  42. 10.1161/01.ATV.15.11.1995 · DOI
  43. 10.1172/JCI118650 · DOI
  44. 10.1161/01.ATV.19.3.611 · DOI
  45. 10.1093/cvr/cvn120 · DOI
  46. 10.1152/physrev.00024.2005 · DOI
  47. 10.2353/ajpath.2007.060857 · DOI
  48. 10.1172/JCI1216 · DOI
  49. 10.1016/S0002-9440(10)63471-2 · DOI
  50. 10.1161/01.RES.0000018941.10726.FA · DOI
  51. 10.1161/01.ATV.18.8.1350 · DOI
  52. Panousis, 2000, J Lipid Res, 41, 75, 10.1016/S0022-2275(20)32076-9 · DOI
  53. 10.1172/JCI115718 · DOI
  54. 10.1161/01.ATV.0000018287.03856.DD · DOI
  55. 10.1161/01.ATV.20.6.1565 · DOI
  56. 10.1172/JCI116425 · DOI
  57. Reiss, 2001, J Lipid Res, 42, 1913, 10.1016/S0022-2275(20)31518-2 · DOI
  58. Feng, 2000, J Lipid Res, 41, 688, 10.1016/S0022-2275(20)32377-4 · DOI
  59. Cornicelli, 2000, J Lipid Res, 41, 376, 10.1016/S0022-2275(20)34476-X · DOI
  60. 10.1194/jlr.M400324-JLR200 · DOI
  61. 10.1074/jbc.M109.040899 · DOI
  62. 10.1096/fj.09-148155 · DOI
  63. 10.1016/j.cardiores.2005.10.018 · DOI
  64. 10.1194/jlr.D000497 · DOI

Cited by

Sorted by citations

See all 157

Metadata

Authors
Wolfs, I., Donners, M., & de Winther, M.
Venue
Thrombosis and Haemostasis
Published
2011
Volume
106
Issue
11
Pages
763-771
ISSN
  • 0340-6245
  • 2567-689X
Cited by
157
References
8
Language
en
Funders
Netherlands Organization for Scientific Research ((grants 2007T067 and 2010B022))

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review